233 related articles for article (PubMed ID: 16966094)
21. Subchronic dose-response study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in female Sprague-Dawley rats.
Van Birgelen AP; Van der Kolk J; Fase KM; Bol I; Poiger H; Brouwer A; Van den Berg M
Toxicol Appl Pharmacol; 1995 May; 132(1):1-13. PubMed ID: 7747272
[TBL] [Abstract][Full Text] [Related]
22. Disposition of 2,3,7,8-tetrabromodibenzo-p-dioxin and 2,3,7,8-tetrachlorodibenzo-p-dioxin in the rat: biliary excretion and induction of cytochromes CYP1A1 and CYP1A2.
Kedderis LB; Diliberto JJ; Linko P; Goldstein JA; Birnbaum LS
Toxicol Appl Pharmacol; 1991 Oct; 111(1):163-72. PubMed ID: 1949032
[TBL] [Abstract][Full Text] [Related]
23. Validation of precision-cut liver slices in dynamic organ culture as an in vitro model for studying CYP1A1 and CYP1A2 induction.
Drahushuk AT; McGarrigle BP; Tai HL; Kitareewan S; Goldstein JA; Olson JR
Toxicol Appl Pharmacol; 1996 Oct; 140(2):393-403. PubMed ID: 8887457
[TBL] [Abstract][Full Text] [Related]
24. Tissue distribution and toxicokinetics of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats after intravenous injection.
Weber LW; Ernst SW; Stahl BU; Rozman K
Fundam Appl Toxicol; 1993 Nov; 21(4):523-34. PubMed ID: 8253305
[TBL] [Abstract][Full Text] [Related]
25. Dose-response relationships for chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in a rat tumor promotion model: quantification and immunolocalization of CYP1A1 and CYP1A2 in the liver.
Tritscher AM; Goldstein JA; Portier CJ; McCoy Z; Clark GC; Lucier GW
Cancer Res; 1992 Jun; 52(12):3436-42. PubMed ID: 1596902
[TBL] [Abstract][Full Text] [Related]
26. Severe 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) intoxication: insights into the measurement of hepatic cytochrome P450 1A2 induction.
Abraham K; Geusau A; Tosun Y; Helge H; Bauer S; Brockmöller J
Clin Pharmacol Ther; 2002 Aug; 72(2):163-74. PubMed ID: 12189363
[TBL] [Abstract][Full Text] [Related]
27. Repeated dose toxicity and relative potency of 1,2,3,4,6,7-hexachloronaphthalene (PCN 66) 1,2,3,5,6,7-hexachloronaphthalene (PCN 67) compared to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) for induction of CYP1A1, CYP1A2 and thymic atrophy in female Harlan Sprague-Dawley rats.
Hooth MJ; Nyska A; Fomby LM; Vasconcelos DY; Vallant M; DeVito MJ; Walker NJ
Toxicology; 2012 Nov; 301(1-3):85-93. PubMed ID: 22813907
[TBL] [Abstract][Full Text] [Related]
28. A mechanistic model of effects of dioxin on gene expression in the rat liver.
Kohn MC; Lucier GW; Clark GC; Sewall C; Tritscher AM; Portier CJ
Toxicol Appl Pharmacol; 1993 May; 120(1):138-54. PubMed ID: 8511776
[TBL] [Abstract][Full Text] [Related]
29. A mechanistic model of effects of dioxin on thyroid hormones in the rat.
Kohn MC; Sewall CH; Lucier GW; Portier CJ
Toxicol Appl Pharmacol; 1996 Jan; 136(1):29-48. PubMed ID: 8560478
[TBL] [Abstract][Full Text] [Related]
30. In utero/lactational and adult exposures to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) show differential effects on craniofacial development and growth in rats.
Sholts SB; Korkalainen M; Simanainen U; Miettinen HM; Håkansson H; Viluksela M
Toxicology; 2015 Nov; 337():30-8. PubMed ID: 26320568
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of [125I]-2-iodo-3,7,8-trichlorodibenzo-p-dioxin in mice: analysis with a physiological modeling approach.
Leung HW; Poland A; Paustenbach DJ; Murray FJ; Andersen ME
Toxicol Appl Pharmacol; 1990 May; 103(3):411-9. PubMed ID: 2339414
[TBL] [Abstract][Full Text] [Related]
32. Extrapolation of a PBPK model for dioxins across dosage regimen, gender, strain, and species.
Wang X; Santostefano MJ; DeVito MJ; Birnbaum LS
Toxicol Sci; 2000 Jul; 56(1):49-60. PubMed ID: 10869453
[TBL] [Abstract][Full Text] [Related]
33. Differential time-course and dose-response relationships of TCDD-induced CYP1B1, CYP1A1, and CYP1A2 proteins in rats.
Santostefano MJ; Ross DG; Savas U; Jefcoate CR; Birnbaum LS
Biochem Biophys Res Commun; 1997 Apr; 233(1):20-4. PubMed ID: 9144388
[TBL] [Abstract][Full Text] [Related]
34. A physiologically based pharmacokinetic model for 2,3,7,8-tetrabromodibenzo-p-dioxin (TBDD) in the rat: tissue distribution and CYP1A induction.
Kedderis LB; Mills JJ; Andersen ME; Birnbaum LS
Toxicol Appl Pharmacol; 1993 Jul; 121(1):87-98. PubMed ID: 8337704
[TBL] [Abstract][Full Text] [Related]
35. Toxicology and carcinogenesis studies of a mixture of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (Cas No. 1746-01-6), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4), and 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) in female Harlan Sprague-Dawley rats (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Sep; (526):1-180. PubMed ID: 17342195
[TBL] [Abstract][Full Text] [Related]
36. Role of CYP1A2 in hepatic sequestration of dioxin: studies using CYP1A2 knock-out mice.
Diliberto JJ; Burgin D; Birnbaum LS
Biochem Biophys Res Commun; 1997 Jul; 236(2):431-3. PubMed ID: 9240455
[TBL] [Abstract][Full Text] [Related]
37. Theophylline pharmacokinetics: comparison of Cyp1a1(-/-) and Cyp1a2(-/-) knockout mice, humanized hCYP1A1_1A2 knock-in mice lacking either the mouse Cyp1a1 or Cyp1a2 gene, and Cyp1(+/+) wild-type mice.
Derkenne S; Curran CP; Shertzer HG; Dalton TP; Dragin N; Nebert DW
Pharmacogenet Genomics; 2005 Jul; 15(7):503-11. PubMed ID: 15970798
[TBL] [Abstract][Full Text] [Related]
38. Relative distribution of 2,3,7,8-tetrachlorodibenzo-p-dioxin in human hepatic and adipose tissues.
Leung HW; Wendling JM; Orth R; Hileman F; Paustenbach DJ
Toxicol Lett; 1990 Feb; 50(2-3):275-82. PubMed ID: 2309246
[TBL] [Abstract][Full Text] [Related]
39. The effects of 2,2',4,4',5,5'-hexachlorobiphenyl cotreatment on the disposition of 2,3,7,8-tetrachlorodibenzo-p-dioxin in mice.
De Jongh J; DeVito M; Diliberto J; Van den Berg M; Birnbaum L
Toxicol Lett; 1995 Oct; 80(1-3):131-7. PubMed ID: 7482580
[TBL] [Abstract][Full Text] [Related]
40. Effect of dose, time, and pretreatment on the biliary excretion and tissue distribution of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the rat.
Kedderis LB; Andersen ME; Birnbaum LS
Fundam Appl Toxicol; 1993 Nov; 21(4):405-11. PubMed ID: 8253293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
